Traditional Chinese medicine composition for treating retinal pigment degeneration

Abstract

The invention relates to the field of traditional Chinese medicine, and discloses a traditional Chinese medicine composition for treating retinal pigment degeneration, containing the following components: 15-20g of radix rehmanniae preparata, 10-15g of rhizoma polygonati, 10-20g of lycium barbarum, 10-15g of cuscuta Chinensis, 10-15g of dogwood, 10-20g of common yam rhizome, 15-20g of poria cocos,10-15g of fructus broussonetiae, 10-15g of cortex moutan, 10-15g of pseudo-ginseng, 10-20g of salvia miltiorrhiza, 10-15g of radix achyranthis bidentatae, 10-20g of angelica sinensis, 10-15g of concha haliotidis, 10-15g of ligusticum wallichii, 10-15g of notopterygium root and 10-15g of rhizoma acori graminei. The traditional Chinese medicine composition is prepared into pellets according to a modern preparation process, is bottled for later use, with 120g in each bottle, and is taken for 10g each time and three time each day, and taken with boiled water after a meal. The treatment effect ofthe traditional Chinese medicine composition for RP is remarkably improved in comparison with medicines on the market.

Description

Technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating retinitis pigmentosa. Background technique [0002] Retinitis pigmentosa (RP) is a group of hereditary retinal diseases characterized by the loss of photoreceptor and pigment epithelial function. Its main clinical features are night blindness, progressive visual field defects, characteristic changes in the fundus, and Abnormalities in the electrooculogram. According to different genetic methods, retinitis pigmentosa can be divided into autosomal dominant, autosomal recessive, chromosomal linkage, and a small number of double gene mutation inheritance and mitochondrial inheritance. The incidence of retinitis pigmentosa in the world is between 1 / 5000-1 / 3000, and it is one of the most common hereditary eye diseases that damage the fundus and cause blindness. Most patients with retinitis pigmentosa develop in adolescence...

AI Technical Summary

Problems solved by technology

The purpose of the present invention is to overcome the disadvantages of the poor curative effect of the current treatment of retinitis pigmentosa, and provide a pure traditional Chinese medicine composition for the treatment of retinitis pigmentosa.

Images